Here, we hypothesize that Manf may mitigate the progression of T2DM by modulating lipid metabolism, inflammation, apoptosis, and proliferation in the liver, adipose, and pancreatic tissues. This evidence concerns the gene MANF and type 2 diabetes mellitus.